AI eye could slash skin cancer surgery time
NCT ID NCT07358637
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an AI-powered imaging tool can accurately detect the edges of common skin cancers before surgery. Researchers will compare AI-OCT scans with standard surgical results in 30 adults with basal cell carcinoma. If the AI works well, it could help surgeons remove the cancer in fewer steps, making treatment faster and cheaper.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI-enhanced Optical Coherence Tomography (imaging test)
- What this could lead to
- If successful, this could lead to fewer surgical stages for skin cancer removal, saving time and reducing costs.
- What could go wrong
- This is a small, early observational study with only 30 participants. The AI may not be accurate enough, and a follow-up trial is needed to test if it actually reduces surgery steps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA OF SKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI-Powered microscope could diagnose skin cancer in minutes
- AI reads social media posts to spot suicide risk in skin cancer patients
- New drug KUP-101A enters first human tests for advanced skin cancers
- New camera could spare skin cancer patients from unnecessary biopsies
- AI boosts skin diagnosis accuracy for GPs in small trial
- New ultrasound technique aims to improve skin cancer surgery outcomes